Facing Triple-Negative Breast Cancer: Chance’s Story

Patient Info: Chance, Female, Under 40 | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

As of February 2025, Chance described follow-up after Stage II BRCA1-associated triple-negative breast cancer and stated that she did not currently have cancer, while continuing close surveillance.

The Patient StoryRead more →

How I Found Out I Had Stage 4 Colon Cancer!

Patient Info: Rachael Marie, Female, Under 40 | Stage IV

Metastatic Site: ovaries, liver

Rachael completed 12 cycles of FOLFOX/oxaliplatin; colonoscopy looked clear, liver lesions had shrunk, and no new lesions were reported, with further surgical planning pending.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Rachael's Patient Story

Patient Info: Rachael, Female, Under 40 | Stage IV

Metastatic Site: Ovaries; liver

As of January 2025, Rachael had completed intensive chemotherapy for Stage IV sigmoid colon cancer involving the ovaries and liver and was awaiting scans to determine whether liver surgery and HIPEC would be next.

The Patient StoryRead more →

Stage IV HR-Positive Breast Cancer: Kate's Patient Story

Patient Info: Kate, Female, Under 40 | Stage IV

Biomarkers: HR-positive

Metastatic Site: lymph nodes near the lungs; chest wall and skin…

Kate was receiving chemotherapy for Stage IV hormone-positive breast cancer, with surgery and radiation discussed as planned next steps but not yet completed in the source.

The Patient StoryRead more →

Stage III BRCA1 Ovarian Cancer: Carla's Survivor Story

Patient Info: Carla Peoples, female | Stage III

Biomarkers: BRCA1 mutation

She was cancer-free after surgery and 6 rounds of chemotherapy and continued olaparib maintenance with CA-125 blood testing every 3 weeks.

MD AndersonRead more →

Breast invasive lobular carcinoma metastatic to the endometrium: hysterectomy and hormone therapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: HER2 negative, PR/HER2 negative.

Metastatic Site: endometrium (endometrial polyp)

No signs of recurrence were reported 18 months after total hysterectomy with bilateral adnexectomy for endometrial metastasis from invasive lobular breast carcinoma, with scheduled follow-up every 3 to 6 months.

PubMed CentralRead more →

Stage III Colorectal Cancer: Jessenia's Patient Story

Patient Info: Jessenia, Female, Under 40 | Stage III

As of September 2024, Jessenia had completed major treatment steps and was adapting to the physical and emotional effects of treatment, including a temporary colostomy; a clear remission/NED status was not stated.

The Patient StoryRead more →

Invasive Lobular Carcinoma: Kristie's Survivor Story

Patient Info: Kristie, Female

As of August 2024, Kristie was focused on survivorship and advocacy after extensive ILC treatment that included 20 weeks of chemotherapy, 25 radiation treatments, 2 years on Verzenio, estrogen blockers, and 5 surgeries.

Lobular Breast Cancer AllianceRead more →

Colorectal Cancer: Paula's Survivor Story

Patient Info: Paula Chambers Raney, Female

Biomarkers: Lynch syndrome negative; broad hereditary panel with no genetic markers reported

As of August 2024, Paula was a 9-year colorectal cancer survivor with no recurrence reported after surgery.

The Patient StoryRead more →

Stage I Invasive Lobular Carcinoma: Jessica's Patient Story

Patient Info: Jessica, Female, 40s | Stage I

Biomarkers: Myriad genetic testing negative; Oncotype DX score 19; RSClin recurrence risk 19%; isolated tumor cells around 1 sentinel lymph node without invasion

As of July 2024, Jessica had completed bilateral mastectomy for Stage IB ILC and was moving forward with radiation and long-term hormone suppression after chemotherapy was not recommended.

Lobular Breast Cancer AllianceRead more →

HR-positive HER2-negative metastatic breast cancer: bone metastases managed with sequential endocrine therapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER 90%+, PR 80%+, HER2-. CA 15-3 was tracked during treatment.

Metastatic Site: skull base; spine; sternum; ribs; left iliac bone;…

Metastatic HR-positive, HER2-negative breast cancer remained under active management; after earlier progression, palbociclib plus fulvestrant and zoledronic acid produced stable/remission findings on PET/CT at 3 months and again 1 year later, with continued 3-month follow-up recommended.

PubMed CentralRead more →

Stage IV Colorectal Cancer: Zykeisha's Survivor Story

Patient Info: Zykeisha Law, Female, Under 40 | Stage IV

Metastatic Site: Liver; lung

As of April 2024, Zykeisha was back in remission after Stage IV colorectal cancer, recurrence involving lung and liver, additional chemotherapy, and multiple major surgeries; her last treatment was in April 2021.

The Patient StoryRead more →

Liliana Bolaños

Patient Info: Anonymized, Female, 40s

Fight Colorectal CancerRead more →

Stage IV Colorectal Cancer: Linda's Patient Story

Patient Info: Linda Hartong, Female, 40s | Stage IV

Metastatic Site: liver

Linda was feeling well enough to continue treatment after right liver resection and 10 chemotherapy cycles, with further surgery and 2 final cycles planned.

Fight Colorectal CancerRead more →

Pembrolizumab and surgery for metastatic dMMR colorectal cancer with major response

Patient Info: Anonymized, female, 50s | Stage IV

Biomarkers: dMMR/MSI-H; MLH1 loss; PMS2 loss; BRAF/RAS wild type; RET::NCOA4 fusion; MLH1 promoter hypermethylation

Metastatic Site: non-regional lymph nodes

Surgery showed a major pathological response with less than 10% viable tumor. Pembrolizumab was restarted after surgery, and no relapse had been documented.

PubMed CentralRead more →

Ovarian cancer chemotherapy continued after paclitaxel-related liver injury

Patient Info: Anonymized, Female, 50s | Stage II

Biomarkers: somatic BRCA1/2 negative

She completed all 6 planned chemotherapy cycles after dose reduction for liver toxicity and then entered routine surveillance.

PubMed CentralRead more →

Stage II Triple-Negative Breast Cancer: Chantal's Survivor Story

Patient Info: Chantal, Female, Under 40 | Stage II

Biomarkers: Triple-negative breast cancer; BRCA1 mutation

As of December 2023, Chantal reported that she did not currently have cancer, was followed by medical oncology every 3-4 months, and used Signatera testing because tumor markers were not reliable for her.

The Patient StoryRead more →

Stage IV Ovarian Cancer: Melbey's Patient Story

Patient Info: Melbey Segovia, Female | Stage IV

Melbey Segovia died on May 4, 2021, about 5 years and 3 months after her February 2016 diagnosis, after three relapses and hospice care.

Dana-FarberRead more →

Stage III Ovarian Cancer: Jaclyn's Patient Story

Patient Info: Jaclyn (Jackie) VanRaaphorst | Stage III

Biomarkers: FRα-positive; CA-125 monitored

AACR later reported that Jackie died on January 16, 2025.

Stage II HR-Positive Invasive Lobular Carcinoma: Megan's Survivor Story

Patient Info: Megan Claire Chase, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2 not reported

As of July 2023, Megan-Claire was in survivorship after Stage II invasive lobular breast cancer, with clear early scans but significant long-term effects, surgical menopause, chronic pain, fatigue, chemo brain, and inability to tolerate recurrence-prevention medications.

The Patient StoryRead more →

Stage IV Colorectal Cancer: Michelle's Survivor Story

Patient Info: Michelle Cappel, Female, 40s | Stage IV

Biomarkers: Lynch syndrome negative; no hereditary genetic markers reported

Metastatic Site: Ovary

As of July 2023, Michelle had achieved no evidence of disease after FOLFOX chemotherapy and 12-hour surgery for Stage IV colorectal cancer with ovarian metastasis, while continuing to live with scan anxiety and surveillance.

The Patient StoryRead more →

My Colorectal Cancer Story: How I Changed My Diet After Cancer

Patient Info: Angelica Allen, Female, Under 40 | Stage III

As of June 2023, Angelica was all-clear after 5 years following Stage III bowel cancer treatment and described survivorship changes in diet, exercise, rest, stress, and emotional healing.

The Patient StoryRead more →

Stage III Colorectal Cancer: Angelica's Survivor Story

Patient Info: Angelica Allen, Female, Under 40 | Stage III

As of June 2023, Angelica had received her 5-year all-clear after Stage III bowel cancer treatment; later colonoscopy surveillance was reassuring and a liver cyst had disappeared.

The Patient StoryRead more →

Stage III Colorectal Cancer: Amy's Survivor Story

Patient Info: Amy, Female, Under 40 | Stage III

Biomarkers: Lynch syndrome

As of April 2023, Amy had no evidence of disease after Stage IIIB Lynch syndrome-associated colorectal cancer treatment, with clear scans/tumor-residue testing and ongoing Lynch syndrome surveillance.

The Patient StoryRead more →